Related Experiment Video
Updated: Sep 18, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Prophylactic Antibiotic use and Outcomes in Infants Undergoing Pyloromyotomy: A Multicenter Propensity Matched Cohort
Kerri A McKie1, Anoosha Moturu2, Dionne A Graham3
1Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Insights
Antimicrobial prophylaxis did not reduce surgical site infections in infants undergoing laparoscopic pyloromyotomy. However, prophylaxis significantly lowered infection rates in infants undergoing open pyloromyotomy, suggesting selective use.
Area of Science:
- Pediatric Surgery
- Infectious Disease Prevention
Background:
- Pediatric surgeons vary in their use of prophylactic antibiotics for infant pyloromyotomy.
- Evidence is needed to guide antibiotic prophylaxis practices.
Purpose of the Study:
- To compare surgical site infection (SSI) rates in infants undergoing pyloromyotomy with and without antimicrobial prophylaxis.
Main Methods:
- A multicenter study of 6093 infants undergoing pyloromyotomy from January 2021 to December 2023.
- Patient-level propensity-matched mixed-effects models were used to compare outcomes.
- Hospital-level analysis assessed the correlation between prophylaxis rates and SSI rates.
Main Results:
- Overall SSI rates were similar with or without prophylaxis (1.6% vs. 1.1%).
- Higher institutional prophylaxis rates did not correlate with lower SSI rates.
- Laparoscopic pyloromyotomy showed no SSI benefit from prophylaxis; open repair showed a significant SSI reduction with prophylaxis (5.1% vs. 1.9%).
Conclusions:
- Routine antimicrobial prophylaxis does not decrease SSI rates in infants undergoing laparoscopic pyloromyotomy.
- Selective antimicrobial prophylaxis is indicated for infants undergoing open pyloromyotomy due to higher SSI risk.
Objective:
To compare outcomes in infants undergoing pyloromyotomy who did and did not receive antimicrobial prophylaxis.
Summary Background Data:
Variation exists among pediatric surgeons in the perceived utility and use of prophylactic antibiotics for infants undergoing pyloromyotomy.
Methods:
We conducted a multicenter study of infants undergoing pyloromyotomy at 148 hospitals participating in NSQIP-Pediatric from January 2021 to December 2023. Outcomes were compared using patient-level propensity-matched mixed-effects models, adjusting for hospital clustering. A complementary hospital-level analysis assessed the correlation between institutional prophylaxis rates and observed-to-expected (O/E) surgical site infection (SSI) rate ratios.
Results:
6093 infants were included, of which 46.6% received prophylaxis. In the propensity-matched analysis, outcomes were similar for SSI (no prophylaxis: 38/2591 [1.6%] vs. prophylaxis: 28/2591 [1.1%], aOR 0.61; 95% CI, 0.37-1.01) and higher rates of prophylaxis use were not correlated with lower SSI O/E rate ratios in the hospital-level analysis (Spearman ρ = 0.11; P = 0.13). In propensity-matched subgroup analyses stratified by operative approach, no benefit was observed in the use of prophylaxis in infants undergoing laparoscopic pyloromyotomy (prophylaxis: 24/2288 [1.1%] vs. no prophylaxis: 25/2288 [1.1%]; aOR, 0.96; 95% CI, 0.55-1.69); however, a significant reduction in SSI rates was observed with open repair (prophylaxis: 6/311 [1.9%] vs. no prophylaxis: 16/311 [5.1%]; aOR 0.36; 95% CI, 0.14-0.93).
Conclusions:
Routine prophylaxis use does not reduce SSI rates in infants undergoing laparoscopic pyloromyotomy; however, a significant reduction in SSI was observed in infants undergoing open repair, suggesting selective prophylaxis is indicated in this higher-risk cohort.
More Related Videos
05:32Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
Published on: September 21, 2015
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Acute Pyelonephritis II: Diagnostic Studies and Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...